American Pharmacy News
  • State Issues
  • Regulatory
  • Federal Issues
  • Industry
  • Innovation
  • Directory
  • State Issues
  • Regulatory
  • Federal Issues
  • Industry
  • Innovation
  • Directory
  • Home
  • »
  • Organizations

Organizations

  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

Applied Genetic Technologies Corporation


Aquestive Therapeutics


Aralez Pharmaceuticals Inc.


Arixa Pharmaceuticals


Astrazeneca Pharmaceuticals Lp


Auxilium


Avanir Pharmaceuticals, Inc.


Baxalta, Inc.


Baxter


Bayer Pharma


Biodelivery Sciences International, Inc


Biogen


Boehringer-Ingelheim


Breckenridge Pharmaceutical, Inc.


Bristol-Myers Squibb


Catamaran


Celgene Corporation


Centers for Medicare and Medicaid Services


Cigna


Covermymeds


  • «
  • 1
  • 2 (current)
  • 3
  • 4
  • 5
  • ...
  • 8
  • 9
  • »
Trending

Diana Harshbarger, U.S. Representative for Tennessee's 1st District

Rep. Harshbarger calls for PBM transparency, oversight: 'It’s time to shine a light on their shady practices'

Sally Pipes, President & CEO of Pacific Research Institute

Pacific Research Institute CEO Pipes on 340B program: It 'has become a major revenue stream for large hospital systems'

Marlon I. Brown, DPA Director

Cannabis Regulatory Agency releases April disciplinary actions against licensees across Michigan

Ted Okon, MBA, Executive Director, Community Oncology Alliance

Community Oncology Alliance Executive Director Okon on 340B: ‘Expanding participation in a flawed program isn’t reform’

Elise Shutzer, Vice President of Public Affairs at PhRMA

PhRMA launches 'Goldmine: Spa Day' campaign targeting 340B hospital drug pricing program

Copyright © 2026 American Pharmacy News. All Rights Reserved.

  • About
  • Contact
  • Privacy Policy
  • Terms of Service

Alerts Sign-up